ALB and metastatic malignant neoplasm: Cell‐free and concentrated ascites reinfusion therapy had lower mortality and in‐hospital costs than paracentesis in metastatic cancer, particularly in males, patients with serum albumin ≤ 2.5 g/dL, and those with non‐gastrointestinal cancer.